The FDA has received 3,276 adverse event reports for cats that name Robenacoxib.
- 3,276 reports name Robenacoxib in cats, which is 2.2% of all 151,164 cat reports. A report counts under every active ingredient it names.
- 48% are marked serious and 17% record a death or euthanasia; across all cat reports those figures are 27% and 9.4%.
- 11% are complaints that the product did not work (19% across all cat reports).
- The clinical signs reported most are not eating, lethargy and anorexia.
- The FDA lists 2 approved animal drug applications containing Robenacoxib for cats, the earliest approved in 2011.
- None of this is a rate. The FDA data does not record how many cats were given Robenacoxib, so it cannot say how often any of this happens.
How the reports break down
| What the reports say | Reports | Share of this medicine's reports | All cat reports |
|---|---|---|---|
| Marked seriousthe FDA record flags the report as serious | 1,585 | 48% | 27% |
| Death or euthanasiathe outcome recorded in the report, with no finding of cause | 547 | 17% | 9.4% |
| Did not worka complaint that the product failed to work, which the FDA files as an adverse event | 375 | 11% | 19% |
| Seizurea seizure or convulsion is among the clinical signs | 113 | 3.5% | 2.6% |
| Not used per labelthe report says the product was not used the way its label directs | 2,039 | 62% | 33% |
Where on the body do the reported signs sit?
Not on the body: Whole body 27% Did not work 5.7%
- Stomach and gut28%not eating, anorexia, vomiting, weight loss and 2 more
- Whole body27%lethargy, fever, death by euthanasia, lethargy and 1 more
- Blood and organ tests15%other abnormal test result, elevated blood urea nitrogen (bun), elevated creatinine, hyperglycaemia and 1 more
- Behaviour13%behavioural disorder, hiding, vocalisation, hyperactivity
- Thirst and urination5.8%not drinking, dehydration
- Did not work5.7%lack of efficacy
- Brain and nerves2.8%ataxia
- Eyes2.6%dilated pupils
Each figure is a share of sign mentions among the 25 signs reported most for Robenacoxib in cats. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.
Clinical signs reported most
- Not eating411 13%
- Lethargy397 12%
- Anorexia315 9.6%
- Lack of efficacy315 9.6%
- Fever312 9.5%
- Behavioural disorder305 9.3%
- Death by euthanasia291 8.9%
- Vomiting284 8.7%
Reports received per year
Is it approved for cats?
The FDA lists 2 approved animal drug applications containing Robenacoxib for cats, the earliest approved in 2011.
What can you do next?
Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.
Where can you go from this result?
This result is one of 94 in the lookup. Open it in the lookup to set it beside another medicine, or read how the counts were collected.
- Esafoxolaner in cats3,248
- Cyclosporine in cats3,030
- Amoxicillin in cats2,970
- Meloxicam in cats3,654
To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.
Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.